GrowthWorks

HIGHLINE is a pre-seed investor and acceleration platform that supports digital startups in securing follow-on capital, leveraging a network of prominent venture capitalists from its offices in Vancouver and Toronto. Unlike traditional accelerators, HIGHLINE operates without rigid start or end dates, allowing founders to seek advice and support at any time. The platform offers access to a premium network and hosts monthly events for founders, fostering an environment for collaboration and growth. Additionally, HIGHLINE addresses fundraising challenges and collaborates with incubators to provide specialized programming tailored to the needs of emerging companies. The organization was formed in August 2014 through the merger of Growlab Ventures and Extreme Startups.

BuildDirect Technologies Inc. operates an online marketplace that connects homeowners and home improvement professionals in North America with global suppliers of building materials. Founded in 1999 and based in Vancouver, Canada, the company offers a wide range of products, including flooring, decking, tiles, and other building materials. Its platform facilitates the buying and selling of these materials, enhancing accessibility for consumers and professionals alike. BuildDirect's services also include BuildDirect Gateway, a global supply chain platform that provides third parties with access to advanced warehousing and logistics solutions, streamlining the shipping process from manufacturing to last-mile delivery. The company generates the majority of its revenue from its primary platform in the United States.

ResponseTek Networks Corp. is a prominent provider of Customer Experience Management (CEM) software that focuses on enhancing customer satisfaction through actionable insights. The company's innovative ResponseTek Listening Platform connects large corporations, such as HSBC and Vodafone, with their customers across various touchpoints, including retail, call centers, online platforms, and mobile applications. By employing diverse methods such as SMS surveys, online data collection, and social media monitoring, ResponseTek delivers a comprehensive view of the customer experience through both quantitative analysis and qualitative feedback. Headquartered in Vancouver, with additional offices in Toronto and London, ResponseTek aims to eliminate information silos within organizations by integrating customer experience data and reporting, ultimately fostering improved customer relationships.

Boreal Genomics Inc. is a biotechnology company that specializes in the development and marketing of technologies for the blood-based detection and monitoring of circulating tumor DNA. Founded in 2007 and headquartered in Los Altos, California, with an additional office in Vancouver, Canada, the company focuses on improving cancer patient care through innovative diagnostic tools and research applications. Its OnTarget platform enables highly sensitive detection and quantification of tumor mutations in plasma, facilitating accurate tumor profiling and real-time monitoring of tumor evolution. Boreal Genomics also offers the Aurora tool, which purifies and concentrates nucleic acids from various sample types, enhancing the accuracy of sequencing in liquid biopsy applications. These technologies aim to guide therapy selection, improve the efficiency of clinical trials, and accelerate drug development processes.

Vitrium Systems Inc. is a Vancouver-based company that specializes in document security and digital rights management (DRM) software. Founded in 2005, it provides solutions for protecting and managing proprietary, confidential, and revenue-generating content, including PDFs, office files, images, and videos. Vitrium's software empowers creators, publishers, and distributors to control access and usage of their documents through features such as military-grade encryption, file-level protection, and extensive DRM controls. The company's offerings include secure file sharing, tracking and analytics, and a central user portal, as well as consulting, implementation, integration, and support services. Vitrium serves a diverse range of industries, including education, research, financial services, media, and technology. Its technology can integrate seamlessly with existing enterprise systems, enhancing content security and providing insights into content consumption by users.

Layer 7 Technologies provides security and management products for API-driven integrations spanning the extended hybrid enterprise. It offers API management solutions such as API Proxy, a virtual API gateway that gives API publishers a tool for securing, orchestrating, and optimizing APIs as well as enforcing SLAs; XML Firewall that is designed to address access, federation, and message security needs in service oriented architecture (SOA) based integrations; SOA Gateway, an API Gateway that provides data translation, contextual routing, SLA management, caching, protocol switching, and B2B functionality; and Mobile Access Gateway, which simplifies the process of adapting internal data, application, and security infrastructure for mobile use. The company also offers developer management solutions, including API Portal, a platform for developer onboarding, engagement, and management; and operations management solutions such as API Service Manager that simplifies API, service, and gateway management across datacenters and the cloud. In addition, it offers identity management solutions, including OAuth Toolkit which empowers users to control access to their APIs; and Security Token Service for API identity translation and federation. Further, the company offers API academy training in the areas of introduction, API design and architecture, API strategy consulting, and hackathon management; IT services, such as architectural consulting, implementation, and operational health check; and gateway, API portal, and administrator training services. The company was founded in 2003 and is based in Vancouver, Canada. Currently, it operates as a subsidiary of CA Technologies.

Bootup Labs was a startup accelerator based in Vancouver, Canada, founded in 2008. It focused on assisting early-stage companies, particularly in the digital media sector, in becoming fundable ventures. The organization recruited promising entrepreneurs and provided them with essential resources, including mentorship, ongoing support, investment, and office space. Through its comprehensive approach, Bootup Labs aimed to help startups define their business models and secure venture financing, ultimately guiding eight companies from inception to a state of readiness for funding.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

Protiva Biotherapeutics, Inc. is a biotechnology company in the development stage that specializes in nucleic acid-based pharmaceutical products. It aims to combat various human diseases, including cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. The company's product pipeline includes Pro 1, a tumor cell growth inhibitor; Pro-101, an siRNA product targeting tumor growth-related proteins; and Pro-B, which inhibits apolipoprotein B expression. Additionally, Protiva develops Pro-EBOV and Pro-MARV, which are designed to inhibit the replication of the Ebola and Marburg viruses, respectively. The company also employs Stable Nucleic-Acid Lipid Particle technology to facilitate the delivery of nucleic acid payloads to target cells. Furthermore, Protiva is engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics is headquartered in Seattle, Washington, with a research and development facility located in Vancouver, Canada. As of 2008, it operates as a subsidiary of Tekmira Pharmaceuticals Corp.

Layer 7 Technologies provides security and management products for API-driven integrations spanning the extended hybrid enterprise. It offers API management solutions such as API Proxy, a virtual API gateway that gives API publishers a tool for securing, orchestrating, and optimizing APIs as well as enforcing SLAs; XML Firewall that is designed to address access, federation, and message security needs in service oriented architecture (SOA) based integrations; SOA Gateway, an API Gateway that provides data translation, contextual routing, SLA management, caching, protocol switching, and B2B functionality; and Mobile Access Gateway, which simplifies the process of adapting internal data, application, and security infrastructure for mobile use. The company also offers developer management solutions, including API Portal, a platform for developer onboarding, engagement, and management; and operations management solutions such as API Service Manager that simplifies API, service, and gateway management across datacenters and the cloud. In addition, it offers identity management solutions, including OAuth Toolkit which empowers users to control access to their APIs; and Security Token Service for API identity translation and federation. Further, the company offers API academy training in the areas of introduction, API design and architecture, API strategy consulting, and hackathon management; IT services, such as architectural consulting, implementation, and operational health check; and gateway, API portal, and administrator training services. The company was founded in 2003 and is based in Vancouver, Canada. Currently, it operates as a subsidiary of CA Technologies.

Protiva Biotherapeutics, Inc. is a biotechnology company in the development stage that specializes in nucleic acid-based pharmaceutical products. It aims to combat various human diseases, including cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. The company's product pipeline includes Pro 1, a tumor cell growth inhibitor; Pro-101, an siRNA product targeting tumor growth-related proteins; and Pro-B, which inhibits apolipoprotein B expression. Additionally, Protiva develops Pro-EBOV and Pro-MARV, which are designed to inhibit the replication of the Ebola and Marburg viruses, respectively. The company also employs Stable Nucleic-Acid Lipid Particle technology to facilitate the delivery of nucleic acid payloads to target cells. Furthermore, Protiva is engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics is headquartered in Seattle, Washington, with a research and development facility located in Vancouver, Canada. As of 2008, it operates as a subsidiary of Tekmira Pharmaceuticals Corp.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.

Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.